Cargando…

Seeking insights into the EPidemiology, treatment and Outcome of Childhood Arthritis through a multinational collaborative effort: Introduction of the EPOCA study

The epidemiology of juvenile idiopathic arthritis (JIA) is variable worldwide. In particular, a wide disparity exists in the prevalence of the diverse disease subtypes across different geographic areas. The therapeutic approach to JIA is not standardized and no established and widely accepted guidel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Consolaro, Alessandro, Ruperto, Nicolino, Filocamo, Giovanni, Lanni, Stefano, Bracciolini, Giulia, Garrone, Marco, Scala, Silvia, Villa, Luca, Silvestri, Giuseppe, Tani, Daniela, Zolesi, Alessandra, Martini, Alberto, Ravelli, Angelo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551702/ https://www.ncbi.nlm.nih.gov/pubmed/23164467 http://dx.doi.org/10.1186/1546-0096-10-39

Ejemplares similares

Cross-cultural adaptation and psychometric evaluation of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) in 54 languages across 52 countries: review of the general methodology
por: Bovis, Francesca, et al.
Publicado: (2018)

A new approach to defining inactive disease, minimal disease activity and parent- and child-acceptable symptom state in juvenile idiopathic arthritis
por: Consolaro, A, et al.
Publicado: (2011)

A multinational study of the epidemiology, treatment and outcome of childhood arthritis (epoca study): preliminary data from 6,940 patients
por: Consolaro, Alessandro, et al.
Publicado: (2014)

PReS-FINAL-2132: Defining criteria for high disease activity in juvenile idiopathic arthritis: definition and validation of juvenile arthritis disease activity score cutoffs
por: Consolaro, A, et al.
Publicado: (2013)

Agreement between objective and subjective definitions of inactive disease, remission and minimal disease activity in juvenile idiopathic arthritis
por: Schiappapietra, B, et al.
Publicado: (2011)

Looking for the best strategy to treat children with new onset juvenile idiopathic arthritis: presentation of the “comparison of STep-up and step-down therapeutic strategies in childhood ARthritiS” (STARS) trial
por: Burrone, Marco, et al.
Publicado: (2022)

Preliminary validation of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) in 403 clinic patients
por: Solari, N, et al.
Publicado: (2008)

Development and initial validation of a new short and simple Health-Related Quality Of Life (HRQL) Questionnaire for Pediatric Rheumatic Diseases (PRD)
por: Palmisani, E, et al.
Publicado: (2008)

Development and initial validation of the parent acceptable symptom state in juvenile idiopathic arthritis (JIA)
por: Filocamo, G, et al.
Publicado: (2008)

Comparison of the accuracy of different definitions of clinical remission (CR) and minimal disease activity (MDA) in juvenile idiopathic arthritis (JIA)
por: Davì, S, et al.
Publicado: (2008)

PReS-FINAL-2143: Treat-to-target strategy in juvenile idiopathic arthritis: experience in 175 newly-diagnosed patients
por: Negro, G, et al.
Publicado: (2013)

IL-1 Inhibition in Systemic Juvenile Idiopathic Arthritis
por: Giancane, Gabriella, et al.
Publicado: (2016)

Impact of involvement of individual joint groups on subdimensions of functional ability scales in juvenile idiopathic arthritis
por: Meiorin, S, et al.
Publicado: (2008)

Final validation of a new composite disease activity score for juvenile idiopathic arthritis: the Juvenile Arthritis Disease Activity Score (JADAS)
por: Consolaro, A, et al.
Publicado: (2008)

Drivers of non-zero physician global scores during periods of inactive disease in juvenile idiopathic arthritis
por: Alongi, Alessandra, et al.
Publicado: (2022)

The Chilean Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
por: Norambuena, Ximena, et al.
Publicado: (2018)

The Italian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
por: Consolaro, Alessandro, et al.
Publicado: (2018)

Comparison of physician's, parent's and patient's global ratings made on linear or 21-circle visual analogue scales (VAS) in juvenile idiopathic arthritis (JIA)
por: Dalprà, S, et al.
Publicado: (2008)

Current Medical Treatments for Juvenile Idiopathic Arthritis
por: Ruperto, Nicolino, et al.
Publicado: (2011)

PReS-FINAL-2141: Clinical features, therapeutic interventions and outcome of 362 patients with macrophage activation syndrome enrolled in a multinational survey
por: Minoia, F, et al.
Publicado: (2013)

Do parent's global rating of well-being and disease activity of children with juvenile idiopathic arthritis yield different information?
por: Ullmann, N, et al.
Publicado: (2008)

The Estonian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
por: Pruunsild, Chris, et al.
Publicado: (2018)

The Georgian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
por: Ioseliani, Maka, et al.
Publicado: (2018)

The Ukrainian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
por: Boyko, Yaryna, et al.
Publicado: (2018)

The Swedish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
por: Ekelund, Maria, et al.
Publicado: (2018)

A controlled trial of intra-articular corticosteroids with or without methotrexate in oligoarticular juvenile idiopathic arthritis
por: Bracciolini, GP, et al.
Publicado: (2014)

Sensitivity and specificity of current diagnostic guidelines in children with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
por: Davì, Sergio, et al.
Publicado: (2011)

Sensitivity and specificity of current diagnostic guidelines in children with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
por: Davì, Sergio, et al.
Publicado: (2011)

Multinational teams and diseconomies of scale in collaborative research
por: Hsiehchen, David, et al.
Publicado: (2015)

The British English version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
por: Martin, Neil, et al.
Publicado: (2018)

The Paraguayan Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
por: Morel Ayala, Zoilo, et al.
Publicado: (2018)

The Ecuadorian Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
por: Mora, Cristina Herrera, et al.
Publicado: (2018)

Periodic fever syndromes in Eastern and Central European countries: results of a pediatric multinational survey
por: Toplak, Nataša, et al.
Publicado: (2010)

PReS-FINAL-2176: Declines in levels of disease activity and physical disability in children with juvenile idiopathic arthritis seen in standard clinical care over the last 25 years
por: Consolaro, A, et al.
Publicado: (2013)

Epoca
Publicado: (1991)

The Portuguese version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
por: Melo-Gomes, Jose Antonio, et al.
Publicado: (2018)

Use of the JADAS criteria to assess efficacy of canakinumab in patients with SJIA – an analysis of 12-week pooled data
por: Ravelli, A, et al.
Publicado: (2014)

Maintenance of efficacy of canakinumab in SJIA at the individual patient level in a 12-week pooled dataset
por: Ravelli, A, et al.
Publicado: (2014)

3.5 Comparison of functional ability in juvenile idiopathic arthritis, juvenile dermatomyositis, juvenile systemic lupus erythematosus and healthy controls. An analysis of the PRINTO database
por: Filocamo, G, et al.
Publicado: (2008)

Agreement between physicians and parents in rating functional ability of children with juvenile idiopathic arthritis
por: Palmisani, Elena, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_6535i9l2ohrp8229ln2cctcll0